|
1) Synenki L, Chandel NS, Budinger GRS, et al. Bronchoalveolar lavage fluid from patients with acute lung injury/acute respiratory distress syndrome induces myofibroblast differentiation. Crit Care Med. 2007; 35: 842-8
|
|
|
|
2) Hong KU, Reynolds SD, Giangreco A, et al. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol. 2001; 24: 671-81
|
|
|
|
|
|
3) Reddy R, Buckley S, Doerken M, et al. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol. 2004; 286: L658-67
|
|
|
|
|
|
4) Douglas IS, del Valle FD, Winn RA, et al. β-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol. 2006; 34: 274-85
|
|
|
|
|
|
5) Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121: 823-35
|
|
|
|
|
|
6) Takeda Y, Mori T, Imabayashi H, et al. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentia-tion？ J Gene Med. 2004; 6: 833-45
|
|
|
|
|
|
7) Lama VN, Smith L, Badri L, et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest. 2007; 117: 989-6
|
|
|
|
|
|
8) Hennrick KT, Keeton AG, Nanua S, et al. Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med. 2007; 175: 1158-64
|
|
|
|
|
|
9) Summer R, Fitzsimmons K, Dwyer D, et al. Isolation of an adult mouse lung mesenchymal progenitor cell population. Am J Respir Cell Mol Biol. 2007; 37: 152-9
|
|
|
|
|
|
10) Reynolds SD, Shen H, Reynolds PR, et al. Molecular and functional properties of lung SP cells. Am J Physiol Lung Cell Mol Physiol. 2007; 292: L972-83
|
|
|
|
|
|
11) Kleeberger W, Versmold A, Rothamel T, et al. Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol. 2003; 162: 1487-94
|
|
|
|
|
|
12) Suratt BT, Cool CD, Serls AE, et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003; 168: 318-22
|
|
|
|
|
|
13) Yamada M, Kubo H, Kobayashi S, et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol. 2004; 172: 1266-72
|
|
|
|
|
|
14) Michael W, Hongliang Guo, Joan E. Gretton, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003; 29: 213-24
|
|
|
|
|
|
15) Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004; 113: 243-52
|
|
|
|
|
|
16) Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol. 2003; 171: 380-9
|
|
|
|
|
|
17) Ishizawa K, Kubo H, Yamada M, et al. Bone marrow-derived cells contribute to lung regene-ration after elastase-induced pulmonary emphysema. FEBS Lett. 2004; 556: 249-52
|
|
|
|
|
|
18) Zander DS, et al. Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipients. Ann Clin Lab Sci. 2006; 36: 47-52
|
|
|
|
|
|
19) Jacqueline C, et al. Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol. 2005; 33: 335-42
|
|
|
|
|
|
20) Kotton DN, et al. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol. 2005; 33: 328-34
|
|
|
|
|
|
21) Kubo H. Is cell therapy in acute lung injury a realistic dream？ Am J Respir Crit Care Med. 2005; 172: 794-5
|
|
|
|
|
|
22) Herzog EL, Arnam JV, Hu B, et al. Lung-specific nuclear reprogramming is accompanied by heterokaryon formation and Y chromosome loss following bone marrow transplantation and secondary inflammation. FASEB J. 2007; 21: 2592-601
|
|
|
|
|
|
23) Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007; 109: 1801-9
|
|
|
|
|
|
24) Yamada M, Kubo H, Ishizawa K, et al. Increased circulating endothelial progenitor cells in bacterial pneumonia patients: evidence that bone marrow derived cells contribute to lung repair. Thorax. 2005; 60: 410-3
|
|
|
|
|
|
25) Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med. 2005; 172: 854-60
|
|
|
|
|
|
26) Moore BB, Murray L, Das A, et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol. 2006; 35: 175-81
|
|
|
|
|
|
27) Rawlins EL, Ostrowski LE, Randell SH, et al. Inaugural Article: Lung development and repair: Contribution of the ciliated lineage. Proc Natl Acad Sci U S A. 2007; 104: 410-7
|
|
|
|
|
|
28) Dominici M, Blanc KL, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006; 8: 315-7
|
|
|
|
|
|
29) Ortiz LA, Treil MD, Fattman C, et al. Interleukin 1 receptor antagonist mediates the anti-inflam-matory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A. 2007; 104: 11002-7
|
|
|
|
|
|
30) Xu J, Woods CR, Mora AL, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol. 2007; 293: L131-41
|
|
|
|
|
|
31) Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007; 179: 1855-63
|
|
|
|
|
|
32) Baber SR, Deng W, Master RG, et al. Intra-tracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007; 292: H1120-8
|
|
|
|
|
|
33) Serrano-Mollar A, Nacher M, Gay-Jordi G, et al. Intratracheal transplantation of alveolar type II cells reverse bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2007; doi: 10. 1164/rccm. 200610-1491OC
|
|
|
|
|
|
34) Andrade CF, Wong AP, Waddell TK, et al. Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol. 2007; 292: L510-8
|
|
|
|
|
|
35) Hampton T. Search Is On for Cells That Repair Heart. JAMA. 2006; 296: 2541
|
|
|
|
|
|
36) Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006; 443: 421-6
|
|
|
|
|
|
37) Carlson ME, Conboy IM. Loss of stem cell regenerative capacity within aged niches. Aging Cell. 2007; 6: 371-82
|
|
|
|
|